{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:13:34Z","timestamp":1790820814493,"version":"4.1.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adult T-cell leukemia-lymphoma (ATL) is an aggressive hematological malignancy of CD4+ T cells transformed by human T-cell lymphotropic virus-1 (HTLV-1). Most HTLV-1\u2013infected individuals are asymptomatic, and only 3% to 5% of carriers develop ATL. Here, we describe the contribution of aberrant DNA methylation to ATL leukemogenesis. HTLV-1\u2013infected T-cells and their uninfected counterparts were separately isolated based on CADM1 and CD7 expression status, and differentially methylated positions (DMPs) specific to HTLV\u2013infected T cells were identified through genome-wide DNA methylation profiling. Accumulation of DNA methylation at hypermethylated DMPs correlated strongly with ATL development and progression. In addition, we identified 22 genes downregulated because of promoter hypermethylation in HTLV-1\u2013infected T cells, including THEMIS, LAIR1, and RNF130, which negatively regulate T-cell receptor (TCR) signaling. Phosphorylation of ZAP-70, a transducer of TCR signaling, was dysregulated in HTLV-1\u2013infected cell lines but was normalized by reexpression of THEMIS. Therefore, we hypothesized that DNA hypermethylation contributes to growth advantages in HTLV-1\u2013infected cells during ATL leukemogenesis. To test this idea, we investigated the anti-ATL activities of OR-1200 and OR-2100 (OR21), novel decitabine (DAC) prodrugs with enhanced oral bioavailability. Both DAC and OR21 inhibited cell growth, accompanied by global DNA hypomethylation, in xenograft tumors established by implantation of HTLV-1\u2013infected cells. OR21 was less hematotoxic than DAC, whereas tumor growth inhibition was almost identical between the 2 compounds, making it suitable for long-term treatment of ATL patient-derived xenograft mice. Our results demonstrate that regional DNA hypermethylation is functionally important for ATL leukemogenesis and an effective therapeutic target.<\/jats:p>","DOI":"10.1182\/blood.2019003084","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T22:51:43Z","timestamp":1589237503000},"page":"871-884","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-4781","authenticated-orcid":false,"given":"Tatsuro","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ureshino","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuharu","family":"Kamachi","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"},{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kurahashi","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"},{"name":"OHARA Pharmaceutical Co., Ltd., Shiga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fukuda-Kurahashi","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"},{"name":"OHARA Pharmaceutical Co., Ltd., Shiga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-4869","authenticated-orcid":false,"given":"Naoko","family":"Hattori","sequence":"additional","affiliation":[{"name":"Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Faculty of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Section of Clinical Cooperation System, Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7428-9068","authenticated-orcid":false,"given":"Naoko","family":"Sueoka-Aragane","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-5206","authenticated-orcid":false,"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-7817","authenticated-orcid":false,"given":"Toshikazu","family":"Ushijima","sequence":"additional","affiliation":[{"name":"Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan;"},{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaburo","family":"Sueoka","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Faculty of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2020081311245704900_B1","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"2020081311245704900_B2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2020081311245704900_B3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmarks analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"24","key":"2020081311245704900_B4","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2020081311245704900_B5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"2020081311245704900_B6","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci"},{"issue":"7","key":"2020081311245704900_B7","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2003-07-2482","article-title":"Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells","volume":"103","author":"Yoshida","year":"2004","journal-title":"Blood"},{"issue":"17","key":"2020081311245704900_B8","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1158\/0008-5472.CAN-04-1422","article-title":"Identification of aberrantly methylated genes in association with adult T-cell leukemia","volume":"64","author":"Yasunaga","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"2020081311245704900_B9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2353\/ajpath.2010.090236","article-title":"Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia\/lymphoma","volume":"176","author":"Sato","year":"2010","journal-title":"Am J Pathol"},{"issue":"4","key":"2020081311245704900_B10","first-page":"1043","article-title":"Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia","volume":"60","author":"Nosaka","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"2020081311245704900_B11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ijc.23749","article-title":"Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia","volume":"123","author":"Taniguchi","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"2020081311245704900_B12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-8935-6-36","article-title":"Aging is associated with highly defined epigenetic changes in the human epidermis","volume":"6","author":"Raddatz","year":"2013","journal-title":"Epigenetics Chromatin"},{"issue":"1","key":"2020081311245704900_B13","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1038\/srep13107","article-title":"Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes","volume":"5","author":"Tserel","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"2020081311245704900_B14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"issue":"11","key":"2020081311245704900_B15","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2020081311245704900_B16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/cas.12639","article-title":"Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry","volume":"106","author":"Kobayashi","year":"2015","journal-title":"Cancer Sci"},{"issue":"13","key":"2020081311245704900_B17","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1158\/0008-5472.CAN-07-0251","article-title":"Delivery of 5-aza-2\u2032-deoxycytidine to cells using oligodeoxynucleotides","volume":"67","author":"Yoo","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"2020081311245704900_B18","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S2352-3026(19)30029-8","article-title":"Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1\/2 trial","volume":"6","author":"Garcia-Manero","year":"2019","journal-title":"Lancet Haematol"},{"issue":"4","key":"2020081311245704900_B19","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(19)30030-4","article-title":"An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study","volume":"6","author":"Savona","year":"2019","journal-title":"Lancet Haematol"},{"issue":"1","key":"2020081311245704900_B20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13148-019-0709-y","article-title":"Novel prodrugs of decitabine with greater metabolic stability and less toxicity","volume":"11","author":"Hattori","year":"2019","journal-title":"Clin Epigenetics"},{"key":"2020081311245704900_B21","doi-asserted-by":"crossref","first-page":"539748","DOI":"10.1155\/2011\/539748","article-title":"Comparative study of human hematopoietic cell engraftment into BALB\/c and C57BL\/6 strain of rag-2\/jak3 double-deficient mice","volume":"2011","author":"Ono","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"2020081311245704900_B22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/epi-2017-0093","article-title":"MACON: a web tool for computing DNA methylation data obtained by the Illumina Infinium Human DNA methylation BeadArray","volume":"10","author":"Iida","year":"2018","journal-title":"Epigenomics"},{"issue":"6","key":"2020081311245704900_B23","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1073\/pnas.1717340115","article-title":"Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues","volume":"115","author":"Yamashita","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020081311245704900_B24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2012.11.022","article-title":"Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers","volume":"330","author":"Kim","year":"2013","journal-title":"Cancer Lett"},{"issue":"1","key":"2020081311245704900_B25","first-page":"95","article-title":"Torin2 potentiates anticancer effects on adult T-cell leukemia\/lymphoma by inhibiting mammalian target of rapamycin","volume":"36","author":"Watanabe","year":"2016","journal-title":"Anticancer Res"},{"issue":"3","key":"2020081311245704900_B26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2020081311245704900_B27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15252\/embj.201387725","article-title":"A THEMIS:SHP1 complex promotes T-cell survival","volume":"34","author":"Paster","year":"2015","journal-title":"EMBO J"},{"issue":"1","key":"2020081311245704900_B28","doi-asserted-by":"crossref","first-page":"e1006120","DOI":"10.1371\/journal.ppat.1006120","article-title":"HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors [published correction appears in PLoS Pathog. 2017;13(2):e10066228]","volume":"13","author":"Kinosada","year":"2017","journal-title":"PLoS Pathog"},{"issue":"2","key":"2020081311245704900_B29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","article-title":"LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes","volume":"7","author":"Meyaard","year":"1997","journal-title":"Immunity"},{"key":"2020081311245704900_B30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gene.2006.01.028","article-title":"h-Goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes","volume":"374","author":"Guais","year":"2006","journal-title":"Gene"},{"issue":"5","key":"2020081311245704900_B31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2010.05.002","article-title":"The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation","volume":"32","author":"Nurieva","year":"2010","journal-title":"Immunity"},{"issue":"7","key":"2020081311245704900_B32","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","article-title":"Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia","volume":"106","author":"Watanabe","year":"2005","journal-title":"Blood"},{"issue":"7683","key":"2020081311245704900_B33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature24649","article-title":"PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis [published correction appears in Nature. 2018;553(7687):238]","volume":"552","author":"Wartewig","year":"2017","journal-title":"Nature"},{"key":"2020081311245704900_B34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2017.03.015","article-title":"The promise of epigenetic therapy: reprogramming the cancer epigenome","volume":"42","author":"Kelly","year":"2017","journal-title":"Curr Opin Genet Dev"},{"issue":"11","key":"2020081311245704900_B35","doi-asserted-by":"crossref","first-page":"e79044","DOI":"10.1371\/journal.pone.0079044","article-title":"Comparison of methods for quantification of global DNA methylation in human cells and tissues","volume":"8","author":"Lisanti","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"2020081311245704900_B36","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.molimm.2005.01.004","article-title":"The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation","volume":"42","author":"Maasho","year":"2005","journal-title":"Mol Immunol"},{"issue":"12","key":"2020081311245704900_B37","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1111\/cas.14219","article-title":"CD4+ CADM1+ cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia\/lymphoma","volume":"110","author":"Makiyama","year":"2019","journal-title":"Cancer Sci"},{"issue":"2","key":"2020081311245704900_B38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-019-0570-3","article-title":"T cell receptor and cytokine signal integration in CD8+ T cells is mediated by the protein Themis","volume":"21","author":"Brzostek","year":"2020","journal-title":"Nat Immunol"},{"issue":"2","key":"2020081311245704900_B39","doi-asserted-by":"crossref","first-page":"e9001","DOI":"10.1371\/journal.pone.0009001","article-title":"A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines","volume":"5","author":"Hollenbach","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"2020081311245704900_B40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41467-018-03513-4","article-title":"RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia [published correction appears in Nat Commun. 2018;9(1):2286]","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"2020081311245704900_B41","first-page":"405","article-title":"Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man","volume":"56","author":"Troetel","year":"1972","journal-title":"Cancer Chemother Rep"},{"issue":"14","key":"2020081311245704900_B42","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2018-01-824607","article-title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies","volume":"132","author":"Shah","year":"2018","journal-title":"Blood"},{"issue":"25","key":"2020081311245704900_B43","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1038\/sj.onc.1211018","article-title":"p21(WAF1\/CIP1) induction by 5-azacytosine nucleosides requires DNA damage","volume":"27","author":"Jiemjit","year":"2008","journal-title":"Oncogene"},{"issue":"10","key":"2020081311245704900_B44","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.18632\/oncotarget.1821","article-title":"The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma","volume":"5","author":"Maes","year":"2014","journal-title":"Oncotarget"},{"issue":"10","key":"2020081311245704900_B45","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1535-7163.MCT-13-0137","article-title":"Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2\u2032-deoxycytidine in solid tumor cells","volume":"12","author":"Venturelli","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2020081311245704900_B46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1367-5931(03)00055-3","article-title":"Profiling drug-like properties in discovery research","volume":"7","author":"Di","year":"2003","journal-title":"Curr Opin Chem Biol"},{"issue":"9","key":"2020081311245704900_B47","doi-asserted-by":"crossref","first-page":"e1002382","DOI":"10.1371\/journal.pmed.1002382","article-title":"Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: a randomized phase 1 study","volume":"14","author":"Molokie","year":"2017","journal-title":"PLoS Med"},{"issue":"23","key":"2020081311245704900_B48","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1158\/0008-5472.CAN-11-1349","article-title":"Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes","volume":"71","author":"Matsusaka","year":"2011","journal-title":"Cancer Res"},{"issue":"19","key":"2020081311245704900_B49","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1158\/1078-0432.CCR-12-3280","article-title":"Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma","volume":"19","author":"Lleras","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"23","key":"2020081311245704900_B50","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1158\/1078-0432.CCR-17-1438","article-title":"Demethylation therapy as a targeted treatment for human papillomavirus-associated head and neck cancer","volume":"23","author":"Biktasova","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2020081311245704900_B51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jmv.24634","article-title":"Decitabine inhibits tumor cell proliferation and up-regulates e-cadherin expression in Epstein-Barr virus-associated gastric cancer","volume":"89","author":"Nakamura","year":"2017","journal-title":"J Med Virol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/7\/871\/1752740\/bloodbld2019003084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/7\/871\/1752740\/bloodbld2019003084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:38:05Z","timestamp":1597379885000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/7\/871\/455059\/Targeting-aberrant-DNA-hypermethylation-as-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,8,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019003084","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}